甜味剂:红醇,醇和心血管风险的朋友或敌人?
Bettina K Wölnerhanssen1,2, Anne Christin Meyer-Gerspach1,2, Arduino Arduini3,4
1St. Clara Research Ltd at St. Claraspital, Kleinriehenstrasse 43, Basel CH-4058, Switzerland.
Cardiovascular research
|May 30, 2025
概括
糖醇如红醇和糖醇可能有助于控制血糖和血小板聚合,有利于代谢综合征患者. 需要对其内源性生产和心血管安全进行进一步的研究.
科学领域:
- 代谢科学 代谢科学
- 心血管研究研究心血管研究
- 营养生物化学 营养生物化学
背景情况:
- 血糖过高会对血管健康产生负面影响,并促进血小板聚合.
- 糖醇,包括红醇和利醇,广泛用于食品,化品和制药.
- 这些化合物对葡萄糖和胰岛素水平的影响最小,并刺激有益的胃肠道激素,如类似葡萄糖类-1.
研究的目的:
- 审查糖醇的生理学,新陈代谢和健康影响,重点关注红醇和糖醇.
- 检查它们对血小板聚合,心血管风险和血管健康的影响.
- 讨论它们在新陈代谢分析中的作用以及对重症患者的影响.
主要方法:
- 关于糖醇的现有研究的文献综述.
- 对生理和代谢数据的分析.
- 检查临床试验和关于心血管影响的观察数据.
主要成果:
- 红醇和西利醇显示出管理高血糖的潜力,并可能影响血小板聚合.
- 目前的证据并没有将糖酒精消费与显著的心血管风险联系起来.
- 糖醇是内生产的,但增加产量的影响需要进一步研究.
结论:
- 糖醇,特别是红醇和西醇,为管理代谢健康状况提供了一个有希望的途径.
- 它们对葡萄糖/胰岛素的最小影响和对血小板功能的潜在益处需要进一步的临床研究.
- 了解内源性产生和长期心血管影响对于全面的风险效益评估至关重要.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
278
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
278
Oral Hypoglycemic Agents: Sulfonylureas
353
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
353
Oral Hypoglycemic Agents: Biguanides and Glitazones
310
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
310
Overview of Carbohydrate Metabolism
2.0K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.0K
Oral Hypoglycemic Agents: Glinides
274
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
274
Glucose Transporters
24.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.3K


